Kendall Law Group, a national securities firm led by a former federal judge with attorneys that include a former U.S. Attorney, is investigating Quest Diagnostics Inc. (NYSE: DGX) for shareholders. The investigation concerns possible breaches of fiduciary duty and other violations of the law by certain officers and directors of the Company. Quest Diagnostics shareholders are urged to contact Scott Kendall of the Kendall Law Group at 877-744-3728 or by email at investor@kendalllawgroup.com.

On May 19, 2011, Quest Diagnostics announced an agreement to pay $241 million to settle state claims that it overcharged Medi-Cal, California's Medicaid program. The settlement is the result of a 2005 lawsuit alleging that the Company systematically overcharged Medi-Cal patients and gave illegal kickbacks to doctors, hospitals and clinics that referred Medi-Cal patients. The Firm’s investigation seeks to determine whether Quest Diagnostics directors and officers breached their fiduciary duties to shareholders by causing or permitting the Company's employees to engage in illegal activities.

Kendall Law Group has the credentials and experience to pursue any type of complex securities litigation. The firm helps shareholders exercise their power to protect their investments when companies break the law. If you are a Quest Diagnostics shareholder, you are encouraged to contact the Kendall Law Group to learn more about your rights.

Copyright Business Wire 2010